Current Therapeutic Leads for the Treatment of Melanoma: Targeted Immunotherapy in the Post-genomic Era

Publisher： Bentham Science Publishers

E-ISSN： 1874-4702|7|1|33-43

ISSN： 1874-4672

Source： Current Molecular Pharmacology, Vol.7, Iss.1, 2014-04, pp. : 33-43

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Emerging therapeutic targets in tuberculosis: post-genomic era

By Khasnobis Shampa   Escuyer Vincent E   Chatterjee Delphi  

Expert Opinion on Therapeutic Targets, Vol. 6, Iss. 1, 2002-02 ,pp. : 21-40

Informa Healthcare

Access to resources Recommend Favorite

Giardiasis in the Post Genomic Era: Treatment, Drug Resistance and Novel Therapeutic Perspectives

By  

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 10, Iss. 4, 2010-08 ,pp. : 283-294

Bentham Science Publishers

Access to resources Recommend Favorite

Identifying Biomarkers of Lung Cancer in the Post-Genomic Era

By  

Current Pharmacogenomics, Vol. 3, Iss. 4, 2005-12 ,pp. : 319-331

Bentham Science Publishers

Access to resources Recommend Favorite

Current therapeutic leads for the treatment of autoimmune diseases: stem cell transplantation and inhibition of post-translational modifications of autoantigens

By Papanastasiou Anastasios D   Chatzantoni Kokona   Mouzaki Athanasia  

Expert Opinion on Drug Discovery, Vol. 3, Iss. 10, 2008-10 ,pp. : 1255-1265

Informa Healthcare

Access to resources Recommend Favorite

Pharmacogenetic Applications of the Post Genomic Era

By  

Current Pharmaceutical Biotechnology, Vol. 3, Iss. 2, 2002-01 ,pp. : 141-150

Bentham Science Publishers

Access to resources Recommend Favorite